TP53 and cancer: Our results suggested that the group scoring high in the lncRNA signature showed significant enrichment in 39 pathways including cell cycle, DNA replication, metabolism, pathways in cancer, NOTCH signaling pathway, mTOR signaling pathway, and P53 signaling pathway (Figs. 6A-C).